Skip to content

Category: Top Stories

Here are Tuesday’s biggest analyst calls: Apple, Broadcom, Intel, Morgan Stanley, Oracle, Wingstop & more

Business Men Break Sit Read Newspaper

Here are the biggest calls on Wall Street on Tuesday.

Delta raises checked bag fees $10 amid jet fuel price surge, joining other carriers

Business Men Break Sit Read Newspaper

Delta is joining United and JetBlue in raising checked bag fees.

Used car prices rise to highest point since summer 2023

Business Men Break Sit Read Newspaper

Used car prices rise to highest point since summer 2023

Trump warns Iran’s ‘whole civilization will die tonight’ unless deal struck

Business Men Break Sit Read Newspaper

The near closure of the Strait of Hormuz since the war began has led to a historic oil supply shock, which quickly sent global energy prices soaring.

This struggling chicken chain is due for a bounce, Citi says

Business Men Break Sit Read Newspaper

The bank upgraded the fast food chain to buy from neutral.

Stocks making the biggest moves premarket: Broadcom, UnitedHealth, Casey’s General Stores and more

Business Men Break Sit Read Newspaper

These are the stocks posting the largest moves in early trading.

House Democrats call on federal regulator to crack down on offshore prediction market war bets

Business Men Break Sit Read Newspaper

Prediction markets like Kalshi and Polymarket have exploded in popularity recently, raising questions about how to properly regulate the platforms.

Time to buy shares of Morgan Stanley, says UBS

Business Men Break Sit Read Newspaper

UBS upgraded Morgan Stanley to buy from neutral.

ASML shares fall after proposed U.S. export curbs target an already fragile China market

Business Men Break Sit Read Newspaper

Proposed U.S. restrictions would target ASML’s deep ultraviolet (DUV) lithography machine, which Chinese companies have so far been able to access.

Novo Nordisk’s explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment

Business Men Break Sit Read Newspaper

CNBC spoke with five U.S. patients who recently started the pill following its launch and have varying initial experiences with the drug.

← Previous
Next →

Ready to take your stock trading to the next level? Sign up now to receive exclusive market analyses, insightful tips, and valuable resources straight to your inbox. Don’t miss out on the opportunity to stay ahead in the ever-evolving world of trading!

JOIN OUR COMMUNITY

Join our growing community of educated investors working together to build wealth with a diversified outlook at investment opportunities

Copyright © 2023. All Rights Reserved.

  • Privacy & Policy
  • Disclaimer